Conditions: Glaucoma Ocular Hypertension
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 300
Healthy volunteers: no

Brief summary:
This study will examine the efficacy and safety of Xalacom comparing with those of Xalatan in Japanese patients with POAG or OH, in order to show superiority of Xalacom over Xalatan in efficacy and similarity of safety between Xalacom and Xalatan.

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: Xalatan intervention 2: Xalacom
Intervention descriptions: intervention 1: latanoprost 0.005%, one rop once daily in evening intervention 2: latanoprost 0.005% adn timolol 0.5%, one drop, once daily

Protocol document: